PHGDH is a targetable driver of PDAC progression
Yumi Kim, Le Jin Sun, Matthew Long, Samantha Caldwell, H. Carlo Maurer, Kenneth P. Olive, Florian A. Karreth, Gina M. DeNicola
This study identifies PHGDH as a driver of PDAC progression by maintaining glutamine metabolism and mTOR signaling, revealing a therapeutic vulnerability to glutamine antagonism in PHGDH-deficient tumors.
bioRxiv · Mar 14, 2026 · PreprintCancer Biology